Contribution of platelet-rich plasma therapy in reproductive health science: A narrative review

Platelet-rich plasma therapy, also truncated as PRP, has been remarkably utilized for quite long in the domains of cardiovascular surgery, orthopaedic treatments, sports medicines etc. Being in the limelight for its remarkable wound healing and cell proliferating activities, it has caught the interest of researchers in the field of reproductive sciences. The chief domain of research has revolved around thin endometrial lining, diminished ovarian content, recurrent implantation failure ailments etc. This article has focused on reviewing existing articles till now on the aetiology of PRP along with methodologies and results in reproductive aberrational conditions. Restrictive research is conducted from Scopus and Web of Science indexed journals, PubMed focusing on the deployment of PRP in infertility science and categorized the result under 3 genres: PRP in refractory attenuated endometrium, PRP in female gonadal abnormalities and PRP in Asherman’s syndrome. Most literature has shown promising results in improvement of thin endometrium, along with increase in AMH (Anti-Mullerian Hormone) level along with decrement of FSH (Follicle Stimulating Hormone) level, thereby improving ovarian reserve. It also showed reduced adhesion in the uterus after hysteroscopy, along with improvement in the menstrual cycle in case of Asherman’s syndrome, thereby increasing chances of clinical pregnancy. However, lack of standardized protocol is a major con in variation of results. Thus, until conclusive RCTs with larger sample size are conducted, PRP should be restricted to the experimental stage for now.